SCHEMBL2633846

SCHEMBL2633846

O=C(NC(CS)C(=O)NC(CO)C(=O)NC(CO)C(=O)O)C(O)CO

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ACE P12821 1/20 0.47
MME P08473 6/20 0.47
KDM4E B2RXH2 1/20 0.43
MAPT P10636 1/20 0.43
THRB P10828 1/20 0.43
ALOX15 P16050 1/20 0.43
NFKB1 P19838 1/20 0.43
PTGS2 P35354 1/20 0.43
THPO P40225 1/20 0.43
RECQL P46063 1/20 0.43
BLM P54132 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
TGFBR1 P36897 3/20 0.42
OR51E2 Q9H255 1/20 0.39
FOLH1 Q04609 1/20 0.38
CA1 P00915 1/20 0.34
CA2 P00918 1/20 0.34
PTGS1 P23219 1/20 0.33
GSTK1 Q9Y2Q3 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6253538 0.98 ACE (0.49) ACEMMEKDM4EMAPTTHRB
SCHEMBL4363673 0.89 ACE (0.58) ACEMMEKDM4EMAPTTHRB
SCHEMBL8216927 0.89 ACE (0.58) ACEMMEKDM4EMAPTTHRB
SCHEMBL321602 0.89 ACE (0.58) ACEMMEKDM4EMAPTTHRB
SCHEMBL7070376 0.87 TGFBR1 (0.52) ACEMMETGFBR1OR51E2FOLH1
SCHEMBL6009831 0.87 TGFBR1 (0.52) ACEMMETGFBR1OR51E2FOLH1
SCHEMBL5424761 0.81 KDM4E (0.69) ACEMMEKDM4EMAPTTHRB
SCHEMBL30945534 0.80 ACE (0.45) ACEMMEKDM4EMAPTTHRB
SCHEMBL2633849 0.79 ACE (0.44) ACEMMEKDM4EMAPTTHRB
SCHEMBL8974998 0.79 ACE (0.44) ACEMMEKDM4EMAPTTHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0979080-A4 A METHOD OF MODULATING AN IMMUNE RESPONSE IN AN INFECTED MAMMAL BY TRANSMUCOSAL ADMINISTRATION OF MODULATING AGENT UNIV JEFFERSON (US) 2005-06-01 EP claimed
EP-1068331-A1 MEDICAMENTS FOR INDUCING CYTOTOXIC T-CELLS GLAXO GROUP LIMITED (GB) 2001-01-17 EP claimed
EP-0979080-A1 A METHOD OF MODULATING AN IMMUNE RESPONSE IN AN INFECTED MAMMAL BY TRANSMUCOSAL ADMINISTRATION OF MODULATING AGENT THOMAS JEFFERSON UNIVERSITY (US) 2000-02-16 EP claimed
WO-1999051750-A1 MEDICAMENTS FOR INDUCING CYTOTOXIC T-CELLS GLAXO GROUP LIMITED (GB) 1999-10-14 WO claimed
WO-1998029121-A1 A METHOD OF MODULATING AN IMMUNE RESPONSE IN AN INFECTED MAMMAL BY TRANSMUCOSAL ADMINISTRATION OF MODULATING AGENT THOMAS JEFFERSON UNIVERSITY (US) 1998-07-09 WO claimed
EP-0669001-A1 DETERMINATION OF PEPTIDE MOTIFS ON MHC MOLECULES. MAX PLANCK GESELLSCHAFT (DE) 1995-08-30 EP claimed
WO-1994011738-A1 DETERMINATION OF PEPTIDE MOTIFS ON MHC MOLECULES MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 1994-05-26 WO claimed
EP-0584136-A1 DETERMINATION OF MOTIFS OF PEPTIDES ON MHC MOLECULES Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 1994-03-02 EP claimed
EP-4346895-A1 METHODS AND COMPOSITION FOR INDUCING AN IMMUNE RESPONSE BY A RECOMBINANT VACCINIA VIRUS University of Rochester (US) 2024-04-10 EP disclosed
WO-2022256188-A1 METHODS AND COMPOSITION FOR INDUCING AN IMMUNE RESPONSE BY A RECOMBINANT VACCINIA VIRUS UNIVERSITY OF ROCHESTER (US) 2022-12-08 WO disclosed
EP-3104870-A1 TAU PEPTIDES, ANTI-TAU ANTIBODIES, AND METHODS OF USE THEREOF Ipierian, Inc. (US) 2016-12-21 EP disclosed
WO-2015122922-A1 TAU PEPTIDES, ANTI-TAU ANTIBODIES, AND METHODS OF USE THEREOF IPIERIAN, INC. (US) 2015-08-20 WO disclosed
WO-2014151687-A2 COMPOSITIONS AND METHODS TO TREAT AIDS UNIVERSITY OF MASSACHUSETTS (US) 2014-09-25 WO disclosed
WO-2014085305-A1 EDIBLE OR INHALABLE COMPOSITIONS HAVING ANTIBODIES AND METHODS OF USE WOOD, LOWELL L., JR. (US) 2014-06-05 WO disclosed
EP-0669001-A1 DETERMINATION OF PEPTIDE MOTIFS ON MHC MOLECULES. MAX PLANCK GESELLSCHAFT (DE) 1995-08-30 EP disclosed
EP-0666919-A1 VACCINE CONTAINING A THIOL PROTEASE Mallinckrodt Veterinary, Inc. (US) 1995-08-16 EP disclosed
WO-1994028925-A1 VACCINE CONTAINING A SERINE PROTEASE MALLINCKRODT VETERINARY INC. (US) 1994-12-22 WO disclosed
WO-1994011738-A1 DETERMINATION OF PEPTIDE MOTIFS ON MHC MOLECULES MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 1994-05-26 WO disclosed
WO-1994009142-A1 VACCINE CONTAINING A THIOL PROTEASE MALLINCKRODT VETERINARY, INC. (US) 1994-04-28 WO disclosed
EP-0584136-A1 DETERMINATION OF MOTIFS OF PEPTIDES ON MHC MOLECULES Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 1994-03-02 EP disclosed